Immunic Reconciled Depreciation from 2010 to 2024

IMUX Stock  USD 1.13  0.08  6.61%   
Immunic Reconciled Depreciation yearly trend continues to be fairly stable with very little volatility. Reconciled Depreciation will likely drop to about 105.5 K in 2024. During the period from 2010 to 2024, Immunic Reconciled Depreciation regression line of annual values had r-squared of  0.76 and arithmetic mean of  611,897. View All Fundamentals
 
Reconciled Depreciation  
First Reported
2012-09-30
Previous Quarter
31 K
Current Value
42 K
Quarterly Volatility
153.3 K
 
Yuan Drop
 
Covid
Check Immunic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immunic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 105.5 K, Interest Expense of 730.2 K or Other Operating Expenses of 54.8 M, as well as many indicators such as Price To Sales Ratio of 17.3 K, Dividend Yield of 0.0064 or PTB Ratio of 1.46. Immunic financial statements analysis is a perfect complement when working with Immunic Valuation or Volatility modules.
  
Check out the analysis of Immunic Correlation against competitors.
For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.

Latest Immunic's Reconciled Depreciation Growth Pattern

Below is the plot of the Reconciled Depreciation of Immunic over the last few years. It is Immunic's Reconciled Depreciation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immunic's overall financial position and show how it may be relating to other accounts over time.
Reconciled Depreciation10 Years Trend
Slightly volatile
   Reconciled Depreciation   
       Timeline  

Immunic Reconciled Depreciation Regression Statistics

Arithmetic Mean611,897
Geometric Mean342,973
Coefficient Of Variation74.65
Mean Deviation427,191
Median998,000
Standard Deviation456,768
Sample Variance208.6B
Range959K
R-Value(0.87)
Mean Square Error54.8B
R-Squared0.76
Significance0.000025
Slope(88,824)
Total Sum of Squares2.9T

Immunic Reconciled Depreciation History

2024105.5 K
2023111 K
202277 K
202185 K
202039 K
201950 K
2018727 K

About Immunic Financial Statements

Immunic investors use historical fundamental indicators, such as Immunic's Reconciled Depreciation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immunic. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Reconciled Depreciation111 K105.5 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immunic Stock Analysis

When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.